ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

Gordon, Hannah; Minozzi, Silvia; Kopylov, Uri; Verstockt, Bram; Chaparro, María; J. Buskens, Christianne; Warusavitarne, Janindra; Agrawal, Manasi; Allocca, Mariangela; Atreya, Raja; Battat, Robert; Bettenworth, Dominik; Bislenghi, Gabriele; R. Brown, Steven; Burisch, Johan; José Casanova, María; Czuber‐Dochan, Wladyslawa; de Groof, Joline; El‐Hussuna, Alaa; Ellul, Pierre; Fidalgo, Catarina; Fiorino, Gionata; P. Gisbert, Javier; Sabino, João; Hanžel, Jurij; D. Holubar, Stefan; Iacucci, Marietta; Iqbal, Nusrat; Kapizioni, Christina; Κarmiris, Konstantinos; Kobayashi, Taku; Gustavo Kotze, Paulo; Luglio, Gaetano; Maaser, Christian; W. Moran, Gordon; M Noor, Nurulamin; Papamichael, Konstantinos; Peros, Georgios; Reenaers, Cathérine; Sica, Giuseppe; Sigall Boneh, Rotem; R. Vavricka, Stephan; Yanai, Henit; Myrelid, Pär; Adamina, Michel; Raine, Tim

doi:10.1093/ecco-jcc/jjae091

Public

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

Published in Journal of Crohn s and Colitis • Jun 15, 2024

Authors:

Hannah Gordon

Silvia Minozzi

Uri Kopylov

Abstract

Crohn’s disease [CD] is a chronic inflammatory bowel disease [IBD] that can result in progressive bowel damage and disability.1 CD can affect individuals of any age, from children to the elderly,2,3 and may cause significant morbidity and impact on quality of life [QoL]. The precise aetiology of CD ...

Subject

Medicine

Crohn's disease

Intensive care medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!